Association of MDR1, CYP3A4*18B, and CYP3A5*3 polymorphisms with cyclosporine pharmacokinetics in Chinese renal transplant recipients

被引：0
|
作者：
Xiao-yan Qiu
Zheng Jiao
Ming Zhang
Long-jin Zhong
Hui-qi Liang
Chun-lai Ma
Liang Zhang
Ming-kang Zhong
机构：
[1] Fudan University,Clinical Pharmacy Laboratory, Huashan Hospital
[2] Fudan University,School of Pharmacy
[3] Fudan University,Department of Nephrology, Huashan Hospital
来源：
European Journal of Clinical Pharmacology | 2008年 / 64卷
关键词：
MDR1; CYP3A4*18B; CYP3A5*3; Cyclosporine; Renal transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] The impact of CYP3A5*3 and CYP3A4*22 polymorphisms on Tacrolimus pharmacokinetics in a caucasian kidney transplant cohort
    Abdel-Kahaar, E.
    Winter, S.
    Schaeffeler, E.
    Olbricht, C.
    Shipkova, M.
    Schwab, M.
    Wieland, E.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2018, 391 : S74 - S74
  • [42] Polymorphisms in CYP3A5, CYP3A4, and ABCB1 are Not Associated With Cyclosporine Pharmacokinetics Nor With Cyclosporine Clinical End Points After Renal Transplantation
    Bouamar, Rachida
    Hesselink, Dennis A.
    van Schaik, Ron H. N.
    Weimar, Willem
    MacPhee, Iain. A. M.
    de Fijter, Johan W.
    van Gelder, Teun
    THERAPEUTIC DRUG MONITORING, 2011, 33 (02) : 178 - 184
  • [43] Effect of CYP3A4*22 and CYP3A4*1B but not CYP3A5*3 polymorphisms on tacrolimus pharmacokinetic model in Tunisian kidney transplant
    Hannachi, Ibtissem
    Ben Fredj, Nadia
    Chadli, Zohra
    Ben Fadhel, Najah
    Ben Romdhane, Haifa
    Touitou, Yvan
    Boughattas, Naceur A.
    Chaabane, Amel
    Aouam, Karim
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2020, 396
  • [44] Polymorphisms in CYP3A5*3 and MDR1, and haplotype, modulate response to plasma levels of tacrolimus in Chinese renal transplant patients
    Wu, Ping
    Ni, Xuefeng
    Wang, Mingli
    Xu, Xianlin
    Luo, Guanghua
    Jiang, Yan
    ANNALS OF TRANSPLANTATION, 2011, 16 (01) : 54 - 60
  • [45] Association of CYP3A5 genotype with the metabolic ratio (MR) of cyclosporine in Chinese renal transplant recipients
    Chu, Xiao-man
    Guo, Lian-qin
    Min, Pei-qing
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 235 - 235
  • [46] Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients
    Tada, H
    Tsuchiya, N
    Satoh, S
    Kagaya, H
    Li, Z
    Sato, K
    Miura, M
    Suzuki, T
    Kato, T
    Habuchi, T
    TRANSPLANTATION PROCEEDINGS, 2005, 37 (04) : 1730 - 1732
  • [47] Association of CYP2C8, CYP3A4, CYP3A5, and ABCB1 polymorphisms with the pharmacokinetics of paclitaxel
    Henningsson, A
    Marsh, S
    Loos, WJ
    Karlsson, MO
    Garsa, A
    Mross, K
    Mielke, S
    Viganò, L
    Locatelli, A
    Verweij, J
    Sparreboom, A
    McLeod, HL
    CLINICAL CANCER RESEARCH, 2005, 11 (22) : 8097 - 8104
  • [48] CYP3A5*3, CYP3A4*1B and MDR1 C3435T genotype distributions in Ecuadorians
    Sinues, Blanca
    Vicente, Jorge
    Fanlo, Ana
    Mayayo-Sinues, Esteban
    Gonzalez-Andrade, Fabricio
    Sanchez-Q, Dora
    Martinez-Jarreta, Begona
    DISEASE MARKERS, 2008, 24 (06) : 325 - 331
  • [49] Impact of the CYP3A5, CYP3A4, COMT, IL-10 and POR Genetic Polymorphisms on Tacrolimus Metabolism in Chinese Renal Transplant Recipients
    Li, Chuan-Jiang
    Li, Liang
    Lin, Li
    Jiang, Hai-Xia
    Zhong, Ze-Yan
    Li, Wei-Mo
    Zhang, Yan-Jun
    Zheng, Ping
    Tan, Xu-Hui
    Zhou, Lin
    PLOS ONE, 2014, 9 (01):
  • [50] Cyclosporine A and tacrolimus blood levels of renal transplant recipients are correlated with the genetic polymorphisms of CYP3A5 and MDR1 C3435T.
    Hauser, IA
    Just, C
    Schaeffeler, E
    Gossmann, J
    Scheuermann, EH
    Schwab, M
    Geiger, H
    Eichelbaum, M
    Gauer, S
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 223 - 223
12345